Icon plc has completed the $143.5 million purchase of Aptiv Solutions, underscoring the heightened M&A activity among pharmaceutical companies.

Aptiv, headquartered in Reston, Virgina, designs clinical trials for the pharmaceutical and biotechnology industries. The company was sold by private equity firm the Halifax Group, venture capital firm SV Life Sciences and PE firm Comvest Partners. 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.